Kenvue Inc. (KVUE)
Sells over-the-counter medicines, vitamins, and personal care products like Tylenol, Neutrogena, and Band-Aid worldwide.
$19.48+0.01%Consumer Defensive
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago-9.8%
The outlook
KVUE is trading above both its 50- and 200-day moving averages, placing it in the middle-to-upper range of its 52-week span. Analyst consensus leans toward Hold, with the average price target sitting about 2% above the current level. The stock's data shows a modest bullish lean overall, though sentiment remains cautious.
What’s behind the score
Analyst consensusHold — 2.8 avg of 12 analysts
Price trendAbove its 50- & 200-day averages
52-week range63% of the way from its 52-week low to high
Price targetAvg target +2% vs current price
Analyst price target
~12-month · 12 analysts$19.83average target+1.8% vs now
Now $19.48
Low $18.00High $23.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$37.40B
52-wk high
$22.74
52-wk low
$14.02
50-day avg
$18.29
200-day avg
$17.44
Trailing P/E
23.2